About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 195 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 195 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 195 trials

CompletedEfficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of schizophreniaNCT02970292·Phoenix, Arizona and 104 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedNBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)The purpose of this study is to evaluate the efficacy, safety, and tolerability of two doses (50 and 100 mg) of NBI-98854 administered once daily for the treatment of Tardive…NCT01688037·Little Rock, Arkansas and 50 others

CompletedEfficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on LurasidoneThe investigators hypothesize that cognitive remediation will be superior to the active control group on the change from baseline to study end point of cognitive remediation phase…NCT01173874·Granada Hills, California and 15 others

CompletedSafety and Efficacy of Cariprazine in Patients With SchizophreniaThe objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of acute exacerbation of schizophrenia.NCT01104766·Little Rock, Arkansas and 57 others

TerminatedRole Functioning Changes NOSDuring this study the investigators will 1) collect measures of social cognition and social functioning in adolescents and young adults who are experiencing early symptoms of a…NCT02505022·Chicago, Illinois

CompletedComparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With SchizophreniaThe purpose of this study is to demonstrate the effectiveness of paliperidone palmitate in patients with Schizophrenia.NCT00589914·Birmingham, Alabama and 81 others

TerminatedStudy Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary EndpointThe purpose of this study is to determine the effect of bifeprunox or risperidone on the body weight of patients with schizophrenia.NCT00366704·Little Rock, Arkansas and 65 others

CompletedOlanzapine Versus An Active Comparator in the Treatment of SchizophreniaThe purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophreniaNCT00036088·El Centro, California and 59 others

CompletedAripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.A Multicenter, Double-blind 16 Week Study on the augmentation of atypical antipsychotic with Aripiprazole in patients with Schizophrenia with inadequate response to antipsychotic…NCT00325689·Little Rock, Arkansas and 47 others

CompletedA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaML-007C-MA-211 is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered ML-007C-MA in inpatient…NCT07038876·Little Rock, Arkansas and 23 others

CompletedStudy to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaThe purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously (SC) as compared to placebo…NCT03503318·Little Rock, Arkansas and 80 others

Terminated28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 YearsThe study will assess the use of paliperidone palmitate compared with oral risperidone in delaying time to relapse in patients recently diagnosed with schizophrenia who are at…NCT00946985·Little Rock, Arkansas and 71 others

TerminatedEfficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of SchizophreniaThis study was conducted to evaluate the efficacy, safety, and tolerability of AVP-786, as compared with placebo, for the treatment of negative symptoms of schizophrenia.NCT03896945·Little Rock, Arkansas and 71 others

Recruiting52-week Open Label Safety-Tolerability StudyPhase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophreniaNCT07369154·Chandler, Arizona and 22 others

Enrolling by invitationLong-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsTo evaluate the long-term safety and tolerability of OLZ/SAM in pediatric subjects with schizophrenia or Bipolar I disorderNCT04987229·Dothan, Alabama and 34 others

RecruitingA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)The purpose of this study is to evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents.NCT07288567·Anaheim, California and 36 others

RecruitingNBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With SchizophreniaThe primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.NCT06963034·Bryant, Arkansas and 20 others

CompletedComparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental IllnessThe study is a three year research project whose aims are to evaluate the willingness of individuals with serious mental illness to initiate the two illness self-management…NCT02421965·Chicago, Illinois

CompletedThinking Skills for Work in Severe Mental IllnessThe purpose of this study is help people with serious mental illness and receiving vocational rehabilitation get and keep the job they want by improving their thinking skills…NCT01926613·Chicago, Illinois and 1 other

TerminatedOculomotor and Spatial Cognition Deficits in SchizophreniaDESCRIPTION: (Verbatim from the Applicant's Abstract) Abnormalities of eye movement control and spatial cognition are well-established deficits in schizophrenia.NCT00931996·Chicago, Illinois

PreviousPage 4 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia